NetScientific PLC ProAxsis Wins Innovative Business of Year in NI
04 Junho 2018 - 3:00AM
RNS Non-Regulatory
TIDMNSCI
NetScientific PLC
04 June 2018
NetScientific plc
("NetScientific" or the "Company" or the "Group")
ProAxsis Winner of Innovative Business of the Year Award in
Northern Ireland
London, UK - June 4(th) , 2018 - NetScientific plc
("NetScientific", AIM: NSCI), the transatlantic healthcare IP
commercialisation group, announces that its portfolio company
ProAxsis has been granted the Innovative Business of the Year award
at the Business Eye First Trust Awards (BEFTAs), an for small
businesses in Northern Ireland. The award, issues by First Trust
Bank, saw ProAxsis emerge the elected winner amongst a group of
companies from diverse sectors.
Commenting on the news, NetScientific's Chief Executive Officer
and Chairman of ProAxsis, Francois R. Martelet said: "We are
extremely pleased with this outcome and want to extend our
congratulations to the ProAxsis team for the ongoing hard work and
dedication. It is splendid to see their efforts materialising and
gaining recognition, and we look forward to their continued
progress for what has been a fantastic year for them thus far."
NetScientific holds 54% of ProAxsis on a fully-diluted
basis.
The full text of the announcement from ProAxsis can be found
below.
# # #
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet,
M.D., CEO
Ian Postlethwaite, CFO
Consilium Strategic Communications
Mary-Jane Elliott Jessica Hodgson Tel: +44 (0)20 3709 5700
/ netscientific@consilium-comms.com
Chris Welsh / Laura Thornton
Stifel Nicolaus Europe Limited Tel: +44 (0) 20 7710 7600
(NOMAD and Broker)
Jonathan Senior / David Arch
/ Ben Maddison
ProAxsis wins Innovative Business of the Year Award
Date: June 4(th) 2018
ProAxsis Limited has been declared as the "Innovative Business
of the Year" at the Business Eye First Trust Awards (BEFTAs) for
small businesses in Northern Ireland.
The glittering awards ceremony took place on the evening of
Thursday May 31(st) at the Crowne Plaza Hotel in Belfast, and was
compered by the UTV newsreader and Northern Ireland correspondent
for ITV, Marc Mallett. Over 400 people were in attendance, with
more than 50 Northern Irish businesses shortlisted across the 14
award categories.
The ProAxsis team were announced as the Innovative Business of
the Year by Tina McKenzie, the Chair of the Federation of Small
Businesses NI, who sponsored the innovation category.
Dr David Ribeiro, CEO of ProAxsis, commented: "This is fabulous
recognition for the whole team at ProAxsis, who work incredibly
hard in order to maximise the potential of our novel ProteaseTag(R)
technology. We're thrilled to have won our first BEFTA, in what was
described as one of the most competitive categories of the event,
and would like to thank the organisers, Business Eye, as well as
the judging panel and the sponsors for the event."
ProAxsis is part of the NetScientific group and is one of the
group's core portfolio companies. The company is also supported by
QUBIS, the commercialisation arm of Queens University.
To find out how ProAxsis can support the measurement of active
protease biomarkers of disease, or for any further queries, please
contact info@proaxsis.com
About NetScientific
NetScientific is a transatlantic healthcare technology group
with an investment strategy focused on sourcing, funding and
commercialising technologies that significantly improve the health
and well-being of people with chronic diseases. For more
information, please visit the website at www.netscientific.net
About ProAxsis Limited:
ProAxsis is developing a range of products for the capture,
detection and measurement of active protease biomarkers of disease.
Its first commercialised immunoassay measures neutrophil elastase,
a leading indicator of infection and inflammation in patients with
Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Disease (COPD)
and bronchiectasis, and an important drug target. The rapid and
easy-to-use tests being developed by ProAxsis incorporate patented
ProteaseTags(R); smart molecules which trap an active protease
within a complex biological sample and enable a visual readout of
its presence. ProteaseTags(R) provide a unique tool to identify and
quantify active protease biomarkers and will assist in the clinical
validation of new therapeutics.
ProAxsis is part of the NetScientific Group and is one of the
Group's core portfolio companies. The company is also supported by
QUBIS, the commercialisation arm of Queens University.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRALIFIIRSIFIIT
(END) Dow Jones Newswires
June 04, 2018 02:00 ET (06:00 GMT)
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024